Drug Pricing Reforms In US Congress: Legacy Systems vs. Cutting-Edge

09 May 2023

• By Grace Moser

A House hearing on bipartisan drug pricing reform bills continues the intense focus on the role of pharmacy benefit managers. But it also shows continued interest in finding ways to make payment systems work for cutting edge gene therapies.

Pills in Capitol Hill forecast — • Source: informa photo illustration

A recent hearing on health cost transparency in the House Energy & Commerce/Health Subcommittee nicely captured the two extremes in play during the current Congressional efforts to further address drug pricing in the US.

The broadly focused hearing looked at new fewer than 17 different bills that would touch on essentially all aspects of...